Physician profile
Taylor Mitchell Jones
NPI 1457910069
$2,849.36
in general payments reported to CMS, 2019-2025
24 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.66 · 2020: $47.64 · 2021: $137 · 2022: $73.04 · 2023: $163 · 2024: $1,989 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,664 · Food and Beverage: $863 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,663.52 |
| Food and Beverage | $862.85 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,722.14 | 2023-2024 | Gelpoint V-Path |
| Novo Nordisk INC | $179.45 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $125.01 | 2021 | |
| Organon LLC | $95.87 | 2023-2025 | Nexplanon |
| Axonics, INC. | $86.15 | 2024 | Axonics |
| Biogen, INC. | $77.48 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $76.18 | 2025 | |
| Baxter Healthcare | $56.27 | 2022 | |
| Medtronic, INC. | $55.05 | 2023-2024 | Plasmablade(Tm), V-Loc 180 |
| Astellas Pharma US INC | $51.88 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $47.95 | 2020-2023 | Fetal Fibronectin Enzyme Immunoassay |
| Exeltis, USA INC. | $40.79 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $36.89 | 2019-2023 | |
| Millicent US INC | $36.74 | 2024 | Intrarosa, Femring |
| Roche Diagnostics Corporation | $22.78 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $22.64 | 2025 | |
| Innovation Technologies INC | $22.06 | 2025 | Irrisept |
| Currax Pharmaceuticals LLC | $17.32 | 2023 | Onzetra Xsail, Contrave |
| Janssen Biotech, INC. | $16.77 | 2022 | |
| Taiho Oncology, INC. | $16.23 | 2019 | |
| Covidien LP | $13.35 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.69 | 2020 | |
| Conmed Corporation | $12.29 | 2021 | |
| Channel Medsystems, INC. | $5.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.